Speaker Spotlight
In Conversation with the Radiotherapy Research PPIE Group
The PPIE group discuss draft content for the ‘Radiotherapy Timeline’ project, developed by PPIE contributors.
The PPIE group discuss draft content for the ‘Radiotherapy Timeline’ project, developed by PPIE contributors.
This year’s Cambridge Festival keynote, The Future of Breast Cancer Care, brings together Professors Jean Abraham and Charlotte Coles with patient representatives to explore how scientific discovery, clinical expertise and lived experience come together to shape tomorrow’s breast cancer treatments.
Ahead of the event, we spoke with members of the Radiotherapy Research Patient and Public Involvement and Engagement (PPIE) Group, who work alongside researchers and clinicians in Cambridge. Here, they reflect on their role, their experiences, and why involving people with lived experience of cancer is essential to improving radiotherapy for future patients.
Tell us about the Radiotherapy Research PPIE Group and what you do
The group brings together people with lived experience of cancer, most of whom have undergone radiotherapy themselves. Collectively, their role is to help make research more grounded in real patient experience. As they explain, “we’re the only ones who truly know what treatment feels like, and that perspective can change how research is designed, communicated and delivered.”
Their work spans reviewing research proposals, shaping trial designs, advising on patient-facing materials, contributing to public events, and supporting scientists in communicating complex ideas in accessible ways. A key part of their mission is also to demystify radiotherapy. One of their most impactful projects has been the creation of a large Radiotherapy Timeline displayed at Addenbrooke’s Hospital, an eye-catching 5.8m x 2.5m installation that charts the evolution of radiotherapy and uses videos, podcasts and QR codes to help people understand how modern, precise and effective the treatment has become.
How does lived experience influence research?
Members describe many situations where their insight has improved the design and acceptability of research studies. One example involved a proposed clinical trial in which patients were due to receive a mammogram immediately after completing radiotherapy. Anyone who has been through treatment knows how sore that area can be; after the group explained this, the study design was changed.
Researchers may ask the group to help refine the language in patient information sheets, rethink the order of procedures, or anticipate practical challenges that may not be obvious from a clinical or laboratory perspective. These small but meaningful adjustments can significantly improve a patient’s experience of joining a study.
One of our contributors took part in a “Bring your patient contributor to work day”, shadowing scientists in the lab and seeing how early-stage research unfolds. Watching experiments, exploring data with researchers and asking questions has helped build a deeper understanding of the science, and researchers say the conversations have, in turn, helped them understand how to communicate their work more effectively.
You run a “Dragon’s Den” style event for research. What happens in those sessions?
This innovative format invites researchers, from early-career scientists to experienced academics, to pitch their ideas to the PPIE panel at a very early stage. Collectively our comments help develop a ‘line of sight’ for the research to clinical application and patient benefit.
Researchers frequently describe the sessions as supportive, energising and “positively challenging”. Many have incorporated the feedback directly into grant applications, plain-English summaries and laboratory plans. The sessions are becoming an important part of the research pipeline in Cambridge, influencing both clinical and pre-clinical radiotherapy studies.
For the PPIE contributors, the experience is equally motivating. Hearing about the breadth of radiotherapy research underway, and knowing that their insights help shape it, creates a sense of partnership and progress.
PPIE contributors in action at one of the 'Dragon’s Den' style events.
PPIE contributors in action at one of the 'Dragon’s Den' style events.
Why is patient involvement in radiotherapy research so important?
The group believes the answer is simple: research is ultimately about people and for people. When those designing studies understand what treatment actually feels like, and when patients understand the science, the partnership produces better outcomes.
They note that many of today’s major advances in cancer care, including shorter radiotherapy schedules and more personalised treatments, only happened because patients took part in research and helped shape the studies behind them. PPIE involvement helps ensure that new treatments are not only effective, but also kinder, more realistic and accessible to those who need them. It is very important to include a diverse patient perspective in early research to help us arrive at the right treatment for everybody.
Our involvement also provides an opportunity to co-produce engagement activities to promote to the public the revolutionary developments in radiotherapy which now provide much more effective and kinder treatments than in the past, including for patients with breast cancer.
We’d encourage anyone who is interested in getting involved with shaping research to join a PPIE group like ours. To join one of the cancer-related PPIE groups in Cambridge, you can find out more here.
What do you hope people will take away from this year’s keynote?
Members hope the audience will see how collaborative breast cancer research truly is, with scientists, clinicians, nurses, patients and carers working side by side. They want people to understand how rapidly radiotherapy and personalised medicine are evolving, and how lived experience is shaping new treatments that are less burdensome and more tailored to each individual.
Above all, they hope the talk will encourage curiosity and show that everyone has something valuable to contribute to the future of cancer research, whether as a patient, supporter, advocate or member of the public.
About the speakers
Professor Jean Abraham
Professor of Precision Breast Cancer Medicine and Director of the Precision Breast Cancer Institute, Jean Abraham is a clinician-scientist focused on personalising treatment for people with breast cancer. She co-leads both the Breast Cancer Virtual Institute and the Integrated Cancer Medicine Virtual Institute within the Cancer Research UK Cambridge Centre, and works as an Honorary Consultant in Medical Oncology.
Jean led the landmark PARTNER trial, which showed that a new treatment approach can significantly improve survival for people with aggressive inherited breast cancer, and revealed how the order in which drugs are given can make a crucial difference. She also leads the Personalised Breast Cancer Programme, which uses whole genome sequencing to help doctors select the best treatment for each patient.
Her goal is clear: to develop smarter, kinder treatments that give patients effective care while avoiding over-treatment and unnecessary side effects.
Professor Charlotte Coles
Professor of Breast Cancer Clinical Oncology at the University of Cambridge, Charlotte Coles is an international leader in breast radiotherapy research and Deputy Head of the Department of Oncology. She co-directs Cancer Research UK RadNet Cambridge, a national network transforming radiation research by bringing discovery science into the clinic.
Charlotte’s research focuses on adapting radiotherapy to an individual patient’s risk of recurrence — aiming for the best chance of cure with the least possible side effects. Over the past two decades she has played a central role in clinical trials showing that, for many breast cancer patients, radiotherapy can be delivered safely in just one week. This shift has changed practice globally, reducing the burden of treatment for patients and health systems alike.
She is also deeply committed to tackling international inequities in cancer care through her work with the Lancet Breast Cancer Commission, ensuring advances benefit patients across the world.
Explore Cancer Research at the Cambridge Festival
Get hands-on with cancer research in Cambridge
Join the Cancer Research UK Cambridge Centre in the CAST building to get hands-on with the ground-breaking cancer research being undertaken by scientists and clinicians across Cambridge.
The future of breast cancer care
Join cancer doctors and patient advocates as they explore how science, medicine and lived experience come together to design the research that matters to patients and the public.
Shades of Survival: Confronting global inequalities in breast cancer (film & discussion)
Join an inspiring evening screening of Shades of Survival, an award-winning international documentary that shines a light on global inequalities in breast cancer care for Black women.
Battling brain cancer: Unspoken stories
As part of Brain Cancer Awareness Month in March 2026, this event will bring together patients, carers, clinicians and researchers for an open conversation about living with, and tackling, brain cancer.
The cancer treatment pipeline: Inside Cambridge’s bench-to-bedside journey
This event reveals how teams at the Cancer Research UK Cambridge Institute work hand in hand with clinicians at Addenbrooke’s Hospital to transform fundamental research into new therapies for patients.
Physical activity and cancer
This interactive session will bring together leading UK experts to discuss current evidence, practical approaches, and real-world challenges related to physical activity for people living with and beyond cancer.
The Cambridge Festival is a mixture of online, on-demand and in-person events covering all aspects of the world-leading research happening at Cambridge. Meet some of the researchers and thought-leaders working in some of the pioneering fields that will impact us all.
Sign up to our mailing list here or keep up to date by following us on social media.
Instagram: Camunifestivals | Facebook: CambridgeFestival |
Bluesky: cambridgefestival.bsky.social| LinkedIn: cambridge-festival

